- Trials with a EudraCT protocol (76)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
76 result(s) found for: Bowel management.
Displaying page 1 of 4.
EudraCT Number: 2006-006855-10 | Sponsor Protocol Number: RXQ229 | Start Date*: 2007-02-23 |
Sponsor Name:Buckinghamshire Hospitals NHS Trust | ||
Full Title: A randomised trial of rectal stimulants for neurogenic bowel management after spinal cord injury | ||
Medical condition: Response of the neurogenic bowel after spinal cord injury to pharmacological rectal stimulants | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2009-013426-16 | Sponsor Protocol Number: 5953 | Start Date*: 2009-11-16 |
Sponsor Name:University of Southampton | ||
Full Title: Management of Irritable Bowel Syndrome in Primary Care: Feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy w... | ||
Medical condition: Irritable Bowel Syndrome | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001405-32 | Sponsor Protocol Number: IMIS2017-02 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Institut des Maladies Génétiques - Imagine | |||||||||||||
Full Title: A Monocentric Single-arm study to characterize the long-term safety, efficacy, and pharmacodynamic of GLP-2 analog (Revestive®) in the management of short bowel syndrome pediatric patients on home-... | |||||||||||||
Medical condition: Short Bowel Syndrom | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005192-89 | Sponsor Protocol Number: C1231001 | Start Date*: 2015-04-21 | |||||||||||
Sponsor Name:Hospira UK Ltd. | |||||||||||||
Full Title: Post-Marketing Observational Cohort Study of Patients with Inflammatory Bowel Disease (IBD) Treated with CT-P13 in Usual Clinical Practice (CONNECT-IBD) | |||||||||||||
Medical condition: Inflamatory Bowel Disease (IBD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001664-34 | Sponsor Protocol Number: 12028-FC-SS | Start Date*: 2013-08-30 | |||||||||||
Sponsor Name:Belfast HSC Trust [...] | |||||||||||||
Full Title: Vit-D in CRC - A Randomised Double Blind Placebo-Controlled Clinical Trial Of a Single Oral Cholecalciferol Treatment Against Surrogate End Point Biomarkers (SEBs) In Colon Cancer (CRC) Patients | |||||||||||||
Medical condition: Colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002739-25 | Sponsor Protocol Number: P/PFI/01 | Start Date*: 2006-09-15 | |||||||||||
Sponsor Name:S.L.A. Pharma (UK) Ltd | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled study to evaluate topical 10%phenylephrine gel applied peri-anally in the management of ileal pouch anal anastomosis (IPAA)-related faecal incontinence | |||||||||||||
Medical condition: Ileal pouch anal anastomosis (IPAA)-related faecal incontinence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005451-15 | Sponsor Protocol Number: IPR/12 | Start Date*: 2006-12-29 | |||||||||||
Sponsor Name:MOLMED | |||||||||||||
Full Title: NGR006 A phase II study of NGR-hTNF administered as single agent every 3 weeks in patients affected by colorectal cancer CRC , previously treated with fluoropyrimidine, oxaliplatin and irinotecan... | |||||||||||||
Medical condition: Patients affected by advanced or metastatic colorectal cancer CRC. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023228-26 | Sponsor Protocol Number: TZP-101-CL-P007 | Start Date*: 2011-02-18 | |||||||||||
Sponsor Name:Tranzyme, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastroin... | |||||||||||||
Medical condition: post-operative ileus in subjects who have undergone partial bowel resection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003187-31 | Sponsor Protocol Number: GN09CA403 | Start Date*: 2015-03-19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:NHS Greater Glasgow & Clyde | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Misoprostol for the Healing of Small Bowel Ulceration in Patients with Obscure Blood Loss while Taking Low-Dose Aspirin or Non-Steroidal Anti-inflammatory Drugs [MASTERS Trial] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Small bowel ulcers associated with iron deficiency anaemia or obscure blood loss in patients using aspirin or non-steroidal anti-inflammatory drugs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023229-38 | Sponsor Protocol Number: TZP-101-CL-P008 | Start Date*: 2011-04-21 | |||||||||||
Sponsor Name:Tranzyme, Inc | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastroin... | |||||||||||||
Medical condition: post-operative ileus in subjects who have undergone partial bowel resection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) CZ (Completed) ES (Ongoing) BG (Completed) HU (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001715-36 | Sponsor Protocol Number: TZP-101-CL-P005 | Start Date*: 2007-07-05 | |||||||||||
Sponsor Name:Tranzyme, Inc | |||||||||||||
Full Title: A Multicenter, Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when Administered as a 30 Minute IV Infusion for Postoperative Ileus to ... | |||||||||||||
Medical condition: Post Operative Ileus (POI) in subjects undergoing major open abdominal surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002003-25 | Sponsor Protocol Number: | Start Date*: 2016-06-02 | |||||||||||
Sponsor Name:Barts Health NHS Trust | |||||||||||||
Full Title: A Phase II Trial of Aflibercept Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Metastatic Colorectal Cancer | |||||||||||||
Medical condition: Metastatic Colorectal Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000239-29 | Sponsor Protocol Number: PEC19156 | Start Date*: 2021-07-09 |
Sponsor Name:BIOGAIA PHARMA | ||
Full Title: A randomized placebo-controlled study to assess safety and preliminary efficacy of BGP345A in patients with constipation due to the use of opioid-based medications for the management of chronic non... | ||
Medical condition: Opioid induced constipation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001050-41 | Sponsor Protocol Number: RP1202 | Start Date*: 2015-06-12 | |||||||||||
Sponsor Name:Robarts Clinical Trials | |||||||||||||
Full Title: A Cluster Randomized Controlled Trial of an Enhanced Treatment Algorithm for the Management of Crohn's Disease | |||||||||||||
Medical condition: Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001234-17 | Sponsor Protocol Number: A3191084 | Start Date*: 2006-06-15 | |||||||||||
Sponsor Name:Pfizer Limited | |||||||||||||
Full Title: Double-blind, triple dummy, parallel-group, randomized, six-month study to compare celecoxib (200 mg BID) with diclofenac SR (75 mg BID) plus omeprazole (20 mg QD) for gastrointestinal events in su... | |||||||||||||
Medical condition: Treatment of osteoarthritis (OA) and/or rheumatoid arthritis (RA) in high GI risk patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) BE (Completed) SE (Completed) CZ (Completed) LT (Completed) DE (Suspended by CA) EE (Completed) PT (Completed) GR (Completed) IE (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003009-40 | Sponsor Protocol Number: CCR4326 | Start Date*: 2015-12-18 | |||||||||||||||||||||
Sponsor Name:Royal Marsden NHS Foundation Trust | |||||||||||||||||||||||
Full Title: Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker to Stratify Management of Good And Poor Responders To Chemoradiotherapy: A Rectal Cancer Multicentre Randomised Control Trial | |||||||||||||||||||||||
Medical condition: Rectal cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004867-19 | Sponsor Protocol Number: v1330032015 | Start Date*: 2015-02-24 |
Sponsor Name:Clinic for General Anesthesiology, Intensive Care and Pain Management | ||
Full Title: Perioperative fluid management in patients receiving major abdominal surgery – Effects of normal saline versus an acetate buffered balanced infusion solution on the necessity of catecholamines for ... | ||
Medical condition: hemodynamic stability of patients undergoing major surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-003258-18 | Sponsor Protocol Number: DOMINO | Start Date*: 2018-03-26 |
Sponsor Name:University Hospital Leuven | ||
Full Title: A randomized controlled trial to evaluate the short-term efficacy and long-term health economic impact of a dietary intervention compared to pharmacotherapy with a musculotropic spasmolytic agent f... | ||
Medical condition: Irritable Bowel Syndrome (IBS); relief of abdominal pain, distension and motility disorders characterised by smooth muscle spasm. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005060-26 | Sponsor Protocol Number: ONU3704 | Start Date*: 2012-06-19 | ||||||||||||||||
Sponsor Name:Purdue Pharma L.P. | ||||||||||||||||||
Full Title: A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess the Analgesic Eff... | ||||||||||||||||||
Medical condition: Opioid-induced Constipation & Moderate to Severe Chronic Low back Pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001814-14 | Sponsor Protocol Number: ABD101684 | Start Date*: 2005-11-21 |
Sponsor Name:GlaxoSmithKline R&D Limited | ||
Full Title: A Double-Blind, Placebo-Controlled, Multicenter Phase IIb Extension Study to Evaluate the Safety and Efficacy of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunc... | ||
Medical condition: Opioid-Induced Bowel Dysfunction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) FI (Prematurely Ended) IE (Completed) CZ (Prematurely Ended) ES (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
